Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study.

@article{Tartour1996PredictorsOC,
  title={Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study.},
  author={Eric Tartour and Jean-Yves Blay and Thierry Dorval and Bernard Escudier and V{\'e}ronique Mosseri and Jean Yves Douillard and Laurent Deneux and Isabelle Gorin and Sylvie N{\'e}grier and Claire Mathiot and Pierre Pouillart and Wolf Herman Fridman},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={1996},
  volume={14 5},
  pages={1697-703}
}
PURPOSE Various parameters have been reported to be correlated with response to interleukin-2 (IL-2) therapy. A multiinstitutional study was performed to assess by multivariate analysis the predictive value of known clinical and biologic melanoma prognostic markers recorded before the onset of IL-2 therapy on the likelihood of objective clinical response. PATIENTS AND METHODS Serum C-reactive protein (CRP), IL-6, and lactate dehydrogenase (LDH) levels were measured in 81 metastatic melanoma… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 31 extracted citations

Melanoma immunotherapy.

Cancer biology & therapy • 2014

Similar Papers

Loading similar papers…